These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


149 related items for PubMed ID: 35797351

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Cabrera Escobar MA, Saayman E, Moorhouse M, Venter WDF, Rees H, TAPS Demonstration Project Team.
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [Abstract] [Full Text] [Related]

  • 3. Sexual health needs of female sex workers in Côte d'Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention.
    Becquet V, Nouaman M, Plazy M, Masumbuko JM, Anoma C, Kouame S, Danel C, Eholie SP, Larmarange J, ANRS 12361 PrEP-CI Study group.
    BMJ Open; 2020 Jan 08; 10(1):e028508. PubMed ID: 31919122
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A community-based healthcare package combining testing and prevention tools, including pre-exposure prophylaxis (PrEP), immediate HIV treatment, management of hepatitis B virus, and sexual and reproductive health (SRH), targeting female sex workers (FSWs) in Côte d'Ivoire: the ANRS 12381 PRINCESSE project.
    Becquet V, Nouaman M, Plazy M, Agoua A, Zébago C, Dao H, Montoyo A, Jary A, Coffie PA, Eholié S, Larmarange J, the ANRS 12381 PRINCESSE team.
    BMC Public Health; 2021 Dec 04; 21(1):2214. PubMed ID: 34863122
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysis.
    Stone J, Bothma R, Gomez GB, Eakle R, Mukandavire C, Subedar H, Fraser H, Boily MC, Schwartz S, Coetzee J, Otwombe K, Milovanovic M, Baral S, Johnson LF, Venter WDF, Rees H, Vickerman P.
    J Int AIDS Soc; 2023 Feb 04; 26(2):e26063. PubMed ID: 36807874
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. How Can Programs Better Support Female Sex Workers to Avoid HIV Infection in Zimbabwe? A Prevention Cascade Analysis.
    Fearon E, Phillips A, Mtetwa S, Chabata ST, Mushati P, Cambiano V, Busza J, Napierala S, Hensen B, Baral S, Weir SS, Rice B, Cowan FM, Hargreaves JR.
    J Acquir Immune Defic Syndr; 2019 May 01; 81(1):24-35. PubMed ID: 30964804
    [Abstract] [Full Text] [Related]

  • 10. Adherence to oral HIV pre-exposure prophylaxis among female sex workers in Kampala, Uganda.
    Nalukwago GK, Isunju JB, Muwonge T, Katairo T, Bunani N, Semitala F, Kyambadde P, Matovu F.
    Afr Health Sci; 2021 Sep 01; 21(3):1048-1058. PubMed ID: 35222566
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparing the impact of increasing condom use or HIV pre-exposure prophylaxis (PrEP) use among female sex workers.
    Mukandavire Z, Mitchell KM, Vickerman P.
    Epidemics; 2016 Mar 01; 14():62-70. PubMed ID: 26972515
    [Abstract] [Full Text] [Related]

  • 14. "Whatever is in the ARVs, is Also in the PrEP" Challenges Associated With Oral Pre-exposure Prophylaxis Use Among Female Sex Workers in South Africa.
    Makhakhe NF, Sliep Y, Meyer-Weitz A.
    Front Public Health; 2022 Mar 01; 10():691729. PubMed ID: 35784260
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa.
    Eakle R, Bothma R, Bourne A, Gumede S, Motsosi K, Rees H.
    PLoS One; 2019 Mar 01; 14(4):e0212271. PubMed ID: 30964874
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Factors Associated with Usage of Oral-PrEP among Female Sex Workers in Nairobi, Kenya, Assessed by Self-Report and a Point-of-Care Urine Tenofovir Immunoassay.
    Shah P, Spinelli M, Irungu E, Kabuti R, Ngurukiri P, Babu H, Kungu M, Champions TMFS, Nyabuto C, Mahero A, Devries K, Kyegombe N, Medley GF, Gafos M, Seeley J, Weiss HA, Kaul R, Gandhi M, Beattie TS, Kimani J.
    AIDS Behav; 2024 Nov 01; 28(11):3836-3849. PubMed ID: 39136824
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.